Q1FY21 results: Lupin net profit drops by 58.88 per cent YoY to Rs 108.7 crore

Lupin Ltd., innovation-led pharmaceutical company, announced its quarterly results on August 6, 2020. The company posted a consolidated net profit of Rs 108.7 crore for Q1FY21, which declined by 58.88 per cent, as compared to Q1FY20 when it reported Rs 264.34 crore.                              

The consolidated net sales reported in Q1FY21 came in at Rs 3,527.86 crore, which declined by 9.02 per cent YoY from Rs 3,877.69 crore in Q1FY20. At EBITDA level, the company stood at Rs 488.08 crore in Q1FY21 that decreased by 34.65 per cent YoY. For Q1FY20, it posted an EBITDA of Rs 746.83 crore.                                                                                                                                                               

EBITDA margin as of Q1FY21 was at 13.84 per cent that declined by 5.42 per cent YoY. The net profit margin in Q1FY21 came in at 3.08 per cent, which declined by 374 per cent YoY. The net profit margin in Q1FY20 was at 6.82 per cent.                                                                                                     

Although, the company’s key businesses in India and United States (US) were affected by the COVID-19 pandemic and subsequent lockdowns impacting revenues, it improved margins by tight expense control.

On Friday, at around 9:32 am, the share is trading 5.04 per cent down at Rs 889.05 on BSE.